World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
23709
World Ranking
11107
National Ranking
4807

Andrew Koff publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Andrew Koff sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 115 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Andrew Koff D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew Koff sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 61 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Andrew Koff is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a notable emphasis on oncology and molecular mechanisms underlying cancer progression and treatment.

The scientist's research contributions frequently cover the following topics:

  • Advanced Breast Cancer Therapies
  • Cancer-related Molecular Pathways
  • Cancer-related cognitive impairment studies
  • Protein Degradation and Inhibitors
  • Cancer Mechanisms and Therapy
  • Sarcoma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers

Koff has published extensively in several key scientific venues, including:

  • Cancer Research
  • Pharmacological Reviews
  • Clinical Cancer Research
  • Cancer Cell
  • bioRxiv (Cold Spring Harbor Laboratory)

The scientist's recent papers illustrate a focus on cell cycle regulation, cancer therapy resistance, and immunotherapy approaches. Selected publications include:

  • INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors, 2021, Cancer Discovery
  • Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma, 2022, Nature Communications
  • Cell cycle dysregulation in cancer, 2024, Pharmacological Reviews
  • Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma, 2023, Clinical Cancer Research
  • Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion, 2024, Cancer Cell

Frequent co-authors in their publications include Sarat Chandarlapaty, Rei Kudo, Pedram Razavi, Anton Safonov, and Hong Shao, indicating collaborative work in cancer biology and therapy-focused research.

The scientist's work incorporates subfields such as Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research, and Pathology and Forensic Medicine, reflecting a multidisciplinary approach to cancer research and treatment development.

Best Publications

  • Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

    Kornelia Polyak;Mong Hong Lee;Hediye Erdjument-Bromage;Andrew Koff

  • p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

    Kornelia Polyak;Jun-ya Kato;Mark J. Solomon;Charles J. Sherr

  • Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27Kip1

    Hiroaki Kiyokawa;Rhonda D Kineman;Katia O Manova-Todorova;Vera C Soares

  • Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle

    Koff A;Giordano A;Desai D;Yamashita K

  • Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

    Andrew Koff;Fred Cross;Alfred L Fisher;Jill Schumacher

  • Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta

    Andrew Koff;Masahiko Ohtsuki;Kornelia Polyak;James M. Roberts

  • Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse

    Antonio Di Cristofano;Marika De Acetis;Andrew Koff;Carlos Cordon-Cardo

  • p53 Regulates Hematopoietic Stem Cell Quiescence

    Yan Liu;Shannon E. Elf;Yasuhiko Miyata;Goro Sashida

  • Cell-cycle inhibitors: three families united by a common cause.

    Anxo Vidal;Andrew Koff

  • Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity.

    Tateki Tsutsui;Bahar Hesabi;David S. Moons;Pier Paolo Pandolfi

  • p27Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells

    Siva Kumar Kolluri;Carsten Weiss;Andrew Koff;Martin Göttlicher

  • Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo.

    E. S. Hoffman;L. Passoni;T. Crompton;T. M. J. Leu

  • The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression.

    C Missero;F Di Cunto;H Kiyokawa;A Koff

  • Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence.

    David B. Agus;Carlos Cordon-Cardo;William Fox;Marija Drobnjak

  • Distinct Altered Patterns of p27KIP1 Gene Expression in Benign Prostatic Hyperplasia and Prostatic Carcinoma

    Carlos Cordon-Cardo;Andrew Koff;Marija Drobnjak;Paola Capodieci

  • CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought.

    Mary E. Klein;Marta Kovatcheva;Lara E. Davis;William D. Tap

  • Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody.

    Xipu Wu;Mark Rubin;Zhen Fan;Tony DeBlasio

  • Formation of p27-CDK complexes during the human mitotic cell cycle

    Timothy J. Soos;Hiroaki Kiyokawa;Jie Shi Yan;Mark Stephen Rubin

  • Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1.

    Patrizia Casaccia-Bonnefil;Ravi Tikoo;Hiroaki Kiyokawa;Victor Friedrich

  • Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle: Science 257, 1689–1694

    A. Koff;V. Dulic;E. Lees;S.I. Reed

Frequent Co-Authors

Samuel Singer
Samuel Singer Memorial Sloan Kettering Cancer Center
Hiroaki Kiyokawa
Hiroaki Kiyokawa Northwestern University
Carlos Cordon-Cardo
Carlos Cordon-Cardo Icahn School of Medicine at Mount Sinai
Stephen D. Nimer
Stephen D. Nimer University of Miami
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Moses V. Chao
Moses V. Chao New York University
Katia Manova
Katia Manova Memorial Sloan Kettering Cancer Center
Eric C. Holland
Eric C. Holland Fred Hutchinson Cancer Research Center
Cristina R. Antonescu
Cristina R. Antonescu Memorial Sloan Kettering Cancer Center
Pier Paolo Pandolfi
Pier Paolo Pandolfi Beth Israel Deaconess Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can expand your career options in Biology and Biochemistry, especially in the health and science sectors. Many professionals transition into healthcare roles through flexible online programs, allowing them to balance work and studies.

For those interested in nursing, rn to bsn online programs offer a convenient way for registered nurses to advance their qualifications and unlock new opportunities in clinical or research settings.

Looking to move into leadership? Consider the fastest online master's in healthcare management to quickly develop management skills relevant to hospitals, labs, or biotech companies.

If mental health is your passion, the psychiatric np programs can prepare you for advanced roles treating patients and leading mental health initiatives.

Nutrition is a natural pathway from biochemistry. The accelerated nutrition degree online can help you specialize in areas like dietetics or wellness coaching in less time.

Choosing an online degree in these areas allows you to align your biology or biochemistry background with today’s most in-demand healthcare and science careers.

Best Scientists Citing Andrew Koff

Trending Scientists

Recently Published Articles